Top compounds associated with response to LCNL1


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC 0.08 0.03
mRNA dexamethasone CTRPv2 pan-cancer AAC 0.071 0.03
mRNA triptolide CTRPv2 pan-cancer AAC -0.074 0.03
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.03
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.04
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.057 0.04
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.04
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC 0.1 0.04
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.062 0.04
mRNA Merck60 CTRPv2 pan-cancer AAC -0.06 0.04
Download CSV